|
AGAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.249880E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.05239999999662E-05 |
| Normal-vs-Stage2 |
1.282150E-03 |
| Normal-vs-Stage3 |
3.067000E-01 |
| Normal-vs-Stage4 |
1.133250E-01 |
| Stage1-vs-Stage2 |
9.072200E-01 |
| Stage1-vs-Stage3 |
4.791600E-02 |
| Stage1-vs-Stage4 |
8.412200E-01 |
| Stage2-vs-Stage3 |
1.170980E-01 |
| Stage2-vs-Stage4 |
7.883200E-01 |
| Stage3-vs-Stage4 |
3.614800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.773840E-04 |
| Normal-vs-AfricanAmerican |
6.578700E-04 |
| Normal-vs-Asian |
6.806400E-02 |
| Caucasian-vs-AfricanAmerican |
8.289400E-01 |
| Caucasian-vs-Asian |
8.961200E-01 |
| AfricanAmerican-vs-Asian |
9.493400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95110000000831E-06 |
| Normal-vs-Female |
4.054800E-01 |
| Male-vs-Female |
1.875660E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.165980E-02 |
| Normal-vs-Extreme_Weight |
3.55499999993292E-07 |
| Normal-vs-Obese |
6.381600E-02 |
| Normal-vs-Extreme_Obese |
5.560300E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.108370E-01 |
| Normal_Weight-vs-Obese |
3.382000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.485400E-01 |
| Extreme_Weight-vs-Obese |
1.478240E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.092400E-01 |
| Obese-vs-Extreme_Obese |
6.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.817600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.860500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.73359999999789E-06 |
| Normal-vs-Age(81-100Yrs) |
2.029400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.511820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.482200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.775400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.804200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.626200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.508200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.51929999994793E-06 |
| Normal-VS-Type2 PRCC |
5.064700E-03 |
| Normal-VS-KIRP CIMP |
2.448400E-01 |
| Normal-VS-Unclassified PRCC |
4.250000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.067000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.608250E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.640400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.362700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.052000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.698100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.99329999999565E-05 |
| Normal-vs-N1 |
8.969200E-01 |
| Normal-vs-N2 |
5.449800E-01 |
| N0-vs-N1 |
1.877720E-02 |
| N0-vs-N2 |
2.593000E-01 |
| N1-vs-N2 |
7.820200E-01 |
|
|
